Estrogen-induced gene expression in bone marrow c-kit+ stem cells and stromal cells: Identification of specific biological processes involved in the functional organization of the stem cell niche

Stem Cells and Development

Volumn 17, Issue 6, 2008, Pages 1153-1163

  Lemieux, Caroline ^a,b   Cloutier, Isabelle ^a   Tanguay, Jean François ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; HERMES ANTIGEN; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENE PROBE; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STROMA CELL;

ANIMALS; ANTIGENS, CD44; BONE MARROW CELLS; CELLS, CULTURED; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; MICE; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS; STROMAL CELLS;

EID: 57449095644     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0251     Document Type: Article

References (54)

1. Forman D and BE Bulwer. (2006). Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle. Curr Treat Options Cardiovasc Med 8:47-57.
2. Wang X, H Hisha, S Taketani, Y Adachi, Q Li, W Cui, Y Cui, J Wang, C Song, T Mizokami, S Okazaki, T Fan, H Fan, Z Lian, ME Gershwin and S Ikehara. (2006). Characterization of mesenchymal stem cells isolated from mouse fetal bone marrow. Stem Cells 24:482-493.
3. Short B, N Brouard, T Occhiodoro-Scott, A Ramakrishnan and PJ Simmons. (2003). Mesenchymal stem cells. Arch Med Res 34:565-571.
4. Muguruma Y, T Yahata, H Miyatake, T Sato, T Uno, J Itoh, S Kato, M Ito, T Hotta and K Ando. (2006). Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107:1878-1887.
5. Wilson A and A Trumpp. (2006). Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6:93-106.
6. Strehlow K, N Werner, J Berweiler, A Link, U Dirnagl, J Priller, K Laufs, L Ghaeni, M Milosevic, M Bohm and G Nickenig. (2003). Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107:3059-3065.
7. Iwakura A, C Luedemann, S Shastry, A Hanley, M Kearney, R Aikawa, JM Isner, T Asahara and DW Losordo. (2003). Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108:3115-3121.
8. Iwakura A, S Shastry, C Luedemann, H Hamada, A Kawamoto, R Kishore, Y Zhu, G Qin, M Silver, T Thorne, L Eaton, H Masuda, T Asahara and DW Losordo. (2006). Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113:1605-1614.
9. Hamada H, MK Kim, A Iwakura, M Ii, T Thorne, G Qin, J Asai, Y Tsutsumi, H Sekiguchi, M Silver, A Wecker, E Bord, Y Zhu, R Kishore and DW Losordo. (2006). Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 114:2261-2270.
10. Imanishi T, T Hano and I Nishio. (2005). Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens 23:1699-1706.
11. Rafii S and D Lyden. (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702-712.
12. Kabrun N, HJ Buhring, K Choi, A Ullrich, W Risau and G Keller. (1997). Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124:2039-2048.
13. Nishikawa SI, S Nishikawa, M Hirashima, N Matsuyoshi and H Kodama. (1998). Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125:1747-1757.
14. Fazel S, M Cimini, L Chen, S Li, D Angoulvant, P Fedak, S Verma, RD Weisel, A Keating and RK Li. (2006). Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116:1865-1877.
15. Fleming WH, EJ Alpern, N Uchida, K Ikuta and IL Weissman. (1993). Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci U S A 90:3760-3764.
16. Heissig B, K Hattori, S Dias, M Friedrich, B Ferris, NR Hackett, RG Crystal, P Besmer, D Lyden, MA Moore, Z Werb and S Rafii. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625-637.
17. Heissig B, Z Werb, S Rafii and K Hattori. (2003). Role of c-kit/Kit ligand signaling in regulating vasculogenesis. Thromb Haemost 90:570-576.
18. Zhu H, N Mitsuhashi, A Klein, LW Barsky, K Weinberg, ML Barr, A Demetriou and GD Wu. (2006). The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24:928-935.
19. Fleiss JL. (1986). The Design and Analysis of Clinical Experiments. John Wiley & Sons, New-York.
20. Schofield R. (1978). The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4:7-25.
21. Li L, LA Milner, Y Deng, M Iwata, A Banta, L Graf, S Marcovina, C Friedman, BJ Trask, L Hood and B Torok-Storb. (1998). The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 8:43-55.
22. Varnum-Finney B, L Xu, C Brashem-Stein, C Nourigat, D Flowers, S Bakkour, WS Pear and ID Bernstein. (2000). Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med 6:1278-1281.
23. Gerber HP, AK Malik, GP Solar, D Sherman, XH Liang, G Meng, K Hong, JC Marsters and N Ferrara. (2002). VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417:954-958.
24. Shintani S, T Murohara, H Ikeda, T Ueno, T Honma, A Katoh, K Sasaki, T Shimada, Y Oike and T Imaizumi. (2001). Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779.
25. Bautz F, S Rafii, L Kanz and R Mohle. (2000). Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Exp Hematol 28:700-706.
26. Cazes A, A Galaup, C Chomel, M Bignon, N Brechot, S Le Jan, H Weber, P Corvol, L Muller, S Germain and C Monnot. (2006). Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 99:1207-1215.
27. Arai F, A Hirao, M Ohmura, H Sato, S Matsuoka, K Takubo, K Ito, GY Koh and T Suda. (2004). Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118:149-161.
28. Quelle DE, RA Ashmun, SA Shurtleff, JY Kato, D Bar-Sagi, MF Roussel and CJ Sherr. (1993). Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7:1559-1571.
29. Roussel MF, AM Theodoras, M Pagano and CJ Sherr. (1995). Rescue of defective mitogenic signaling by D-type cyclins. Proc Natl Acad Sci USA 92:6837-6841.
30. Opitz OG, Y Suliman, WC Hahn, H Harada, HE Blum and AK Rustgi. (2001). Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. J Clin Invest 108:725-732.
31. Sasaki Y, CT Jensen, S Karlsson and SE Jacobsen. (2004). Enforced expression of cyclin D2 enhances the proliferative potential of myeloid progenitors, accelerates in vivo myeloid reconstitution, and promotes rescue of mice from lethal myeloablation. Blood 104:986-992.
32. Kovacs CJ, JA Kerr, BM Daly, MJ Evans and RM Johnke. (1998). Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression. Anticancer Res 18:1805-1812.
33. Lebedev VG, BB Moroz, B Deshevoi Iu and AV Lyrshchikova. (2004). [Role of hematopoietic microenvironment in the mechanism of radioprotective action of interleukin-1 beta in long-term bone marrow cultures]. Radiats Biol Radioecol 44:170-175.
34. Xiong Y, KA Donovan, MP Kline, MK Gornet, LL Moon-Tasson, MQ Lacy, A Dispenzieri, MA Gertz, PR Greipp and JA Lust. (2006). Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1. J Interferon Cytokine Res 26:83-95.
35. Miura N, S Okada, KM Zsebo, Y Miura and T Suda. (1993). Rat stem cell factor and IL-6 preferentially support the proliferation of c-kit-positive murine hemopoietic cells rather than their differentiation. Exp Hematol 21:143-149.
36. Jenkins BJ, AW Roberts, M Najdovska, D Grail and M Ernst. (2005). The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis. Blood 105:3512-3520.
37. Rappold I, SM Watt, N Kusadasi, S Rose-John, J Hatzfeld and RE Ploemacher. (1999). Gp130-signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitors. Leukemia 13:2036-2048.
38. Kang YJ, SJ Yang, G Park, B Cho, CK Min, TY Kim, JS Lee and IH Oh. (2007). A novel function of interleukin-10 promoting self-renewal of hematopoietic stem cells. Stem Cells 25:1814-1822.
39. Fossiez F, O Djossou, P Chomarat, L Flores-Romo, S Ait-Yahia, C Maat, JJ Pin, P Garrone, E Garcia, S Saeland, D Blanchard, C Gaillard, B Das Mahapatra, E Rouvier, P Golstein, J Banchereau and S Lebecque. (1996). T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593-2603.
40. Subramaniam SV, LL Pearson and SE Adunyah. (1999). Interleukin-17 induces rapid tyrosine phosphorylation and activation of raf-1 kinase in human monocytic progenitor cell line U937. Biochem Biophys Res Commun 259:172-177.
41. Jovcic G, D Bugarski, M Petakov, A Krstic, M Vlaski, N Stojanovic and P Milenkovic. (2004). In vivo effects of interleukin-17 on haematopoietic cells and cytokine release in normal mice. Cell Prolif 37:401-412.
42. Broxmeyer HE, T Starnes, H Ramsey, S Cooper, R Dahl, E Williamson and R Hromas. (2006). The IL-17 cytokine family members are inhibitors of human hematopoietic progenitor proliferation. Blood 108:770.
43. Keller JR, GK Sing, LR Ellingsworth, SK Ruscetti and FW Ruscetti. (1990). Two forms of transforming growth factor-beta are equally potent selective growth inhibitors of early murine hematopoiesis. Ann NY Acad Sci 593:172-180.
44. Wilson A, MJ Murphy, T Oskarsson, K Kaloulis, MD Bettess, GM Oser, AC Pasche, C Knabenhans, HR Macdonald and A Trumpp. (2004). c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18:2747-2763.
45. Papayannopoulou T. (2004). Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 103:1580-1585.
46. Zhang J, C Niu, L Ye, H Huang, X He, WG Tong, J Ross, J Haug, T Johnson, JQ Feng, S Harris, LM Wiedemann, Y Mishina and L Li. (2003). Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836-841.
47. Dar A, O Kollet and T Lapidot. (2006). Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 34:967-975.
48. Wynn RF, CA Hart, C Corradi-Perini, L O'Neill, CA Evans, JE Wraith, LJ Fairbairn and I Bellantuono. (2004). A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104:2643-2645.
49. Bhakta S, P Hong and O Koc. (2006). The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Cardiovasc Revasc Med 7:19-24.
50. Mohle R and L Kanz. (2007). Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol 44:193-202.
51. McQuibban GA, GS Butler, JH Gong, L Bendall, C Power, I Clark-Lewis and CM Overall. (2001). Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276:43503-43508.
52. Avigdor A, S Schwartz, P Goichberg, I Petit, I Hardan, I Resnick, S Slavin, A Nagler and T Lapidot. (2004). Membrane type 1-matrix metalloproteinase is directly involved in G-CSF induced human hematopoietic stem and progenitor cell mobilization [abstract]. Blood 104.
53. Shirvaikar N, J Montano, A Turner, M Ratajczak and A Janowska-Wieczorek. (2004). Upregulation of MT1-MMP expression by hyaluronic acid enhances homing-related responses of hematopoietic CD34(+) cells to an SDF-1 gradient [abstract]. Blood 104.
54. Annabi B, YT Lee, S Turcotte, E Naud, RR Desrosiers, M Champagne, N Eliopoulos, J Galipeau and R Beliveau. (2003). Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells 21:337-347.